PE20130283A1 - Cristal de compuesto de amida - Google Patents
Cristal de compuesto de amidaInfo
- Publication number
- PE20130283A1 PE20130283A1 PE2012002427A PE2012002427A PE20130283A1 PE 20130283 A1 PE20130283 A1 PE 20130283A1 PE 2012002427 A PE2012002427 A PE 2012002427A PE 2012002427 A PE2012002427 A PE 2012002427A PE 20130283 A1 PE20130283 A1 PE 20130283A1
- Authority
- PE
- Peru
- Prior art keywords
- amida
- compound crystal
- crystal
- methoxibutyl
- interplan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
SE REFIERE A UN CRISTAL DE CLORHIDRATO DE 1-(4-METOXIBUTIL)-N-(2-METILPROPIL)-N-[(3S,5R)-5-(MORFOLIN-4-ILCARBONIL)PIPERIDIN-3-IL]-1H-BENCIMIDAZOL-2-CARBOXAMIDA CON UN PATRON DE DIFRACCION DE RAYOS X DE POLVO CON CARACTERISTICAS PICO EN LOS ESPACIAMIENTOS INTERPLANOS (d) DE ALREDEDOR DE 26.43 ± 0.2, 7.62 ± 0.2, 4.32 ± 0.2, 3.08 ± 0.2, 2.59 ± 0.2 Y 2.33 ± 0.2 ANGSTROMS. DICHO CRISTAL ES INHIBIDOR DE RENINA SIENDO UTIL COMO AGENTE PROFILACTICO O TERAPEUTICO DE LA HIPERTENSION
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010137194 | 2010-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20130283A1 true PE20130283A1 (es) | 2013-03-25 |
Family
ID=45348277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2012002427A PE20130283A1 (es) | 2010-06-16 | 2011-06-15 | Cristal de compuesto de amida |
Country Status (27)
Country | Link |
---|---|
US (1) | US9018374B2 (es) |
EP (1) | EP2583967B1 (es) |
JP (1) | JP5782438B2 (es) |
KR (1) | KR20130119903A (es) |
CN (1) | CN103068816B (es) |
AU (1) | AU2011266099B2 (es) |
BR (1) | BR112012032055B8 (es) |
CA (1) | CA2802483C (es) |
CL (1) | CL2012003526A1 (es) |
CO (1) | CO6670573A2 (es) |
DO (1) | DOP2012000313A (es) |
EA (1) | EA022094B1 (es) |
EC (1) | ECSP13012392A (es) |
ES (1) | ES2524896T3 (es) |
GE (1) | GEP20146195B (es) |
HK (1) | HK1179605A1 (es) |
IL (1) | IL223562A (es) |
MA (1) | MA34378B1 (es) |
MX (1) | MX2012014828A (es) |
MY (1) | MY163927A (es) |
PE (1) | PE20130283A1 (es) |
SG (1) | SG186223A1 (es) |
TN (1) | TN2012000589A1 (es) |
TW (1) | TWI511967B (es) |
UA (1) | UA108888C2 (es) |
WO (1) | WO2011158880A1 (es) |
ZA (1) | ZA201300065B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104781226A (zh) * | 2012-02-14 | 2015-07-15 | 陶氏环球技术有限责任公司 | 非离子型表面活性剂组合物 |
WO2013122260A1 (en) | 2012-02-15 | 2013-08-22 | Takeda Pharmaceutical Company Limited | Tablet |
CN103831159B (zh) * | 2014-01-20 | 2016-04-13 | 华润赛科药业有限责任公司 | 一种阿齐沙坦微粉化方法 |
US9878981B2 (en) * | 2014-04-10 | 2018-01-30 | Takeda Pharmaceutical Company Limited | Method for producing heterocyclic compound |
GB2542876B (en) * | 2015-04-20 | 2019-10-23 | Johnson Matthey Plc | Structure Directing Agent |
CN107595853A (zh) * | 2017-10-25 | 2018-01-19 | 桂林浩新科技服务有限公司 | 一种用于治疗高血压合并冠心病的药物组合物及其用途 |
CN107595842A (zh) * | 2017-10-25 | 2018-01-19 | 桂林浩新科技服务有限公司 | 一种药物复方制剂及在制备治疗高血压合并冠心病的药物中的用途 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1072649C (zh) | 1995-09-13 | 2001-10-10 | 武田药品工业株式会社 | 苯并氧杂吖庚因化合物,其生产方法和用途 |
CO4940418A1 (es) | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
WO2002006234A1 (fr) | 2000-07-17 | 2002-01-24 | Takeda Chemical Industries, Ltd. | Derives de sulfonate, procede de production et utilisation de ces derives |
US7342117B2 (en) | 2001-10-30 | 2008-03-11 | Astellas Pharma Inc. | α-form or β-form crystal of acetanilide derivative |
AU2003278600A1 (en) | 2002-11-01 | 2004-05-25 | Takeda Pharmaceutical Company Limited | Agent for preventing or treating neuropathy |
EP1559422B1 (en) | 2002-11-08 | 2014-04-30 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
AU2003284596A1 (en) | 2002-11-22 | 2004-06-18 | Takeda Pharmaceutical Company Limited | Imidazole derivative, process for producing the same, and use |
JP3618341B2 (ja) * | 2003-04-15 | 2005-02-09 | 山之内製薬株式会社 | 臭化物及びその結晶 |
EP1614686B1 (en) | 2003-04-15 | 2014-05-07 | Astellas Pharma Inc. | Bromide and its crystal |
WO2004106276A1 (ja) | 2003-05-30 | 2004-12-09 | Takeda Pharmaceutical Company Limited | 縮合環化合物 |
CA2527033A1 (en) | 2003-06-18 | 2004-12-23 | Astrazeneca Ab | 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators |
US7534887B2 (en) | 2003-09-30 | 2009-05-19 | Takeda Pharmaceutical Company Limited | Thiazoline derivative and use of the same |
US7820673B2 (en) | 2003-12-17 | 2010-10-26 | Takeda Pharmaceutical Company Limited | Urea derivative, process for producing the same, and use |
CA2551610A1 (en) | 2003-12-25 | 2005-07-14 | Takeda Pharmaceutical Company Limited | 3-(4-benzyloxyphenyl)propanoic acid derivatives |
WO2005063725A1 (ja) | 2003-12-26 | 2005-07-14 | Takeda Pharmaceutical Company Limited | フェニルプロパン酸誘導体 |
US7786165B2 (en) | 2004-03-15 | 2010-08-31 | Takeda Pharmaceutical Company Limited | Aminophenylpropanoic acid derivative |
WO2005095338A1 (ja) | 2004-03-30 | 2005-10-13 | Takeda Pharmaceutical Company Limited | アルコキシフェニルプロパン酸誘導体 |
TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
CA2605778A1 (en) | 2005-04-20 | 2006-10-26 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
JP5044398B2 (ja) | 2005-06-09 | 2012-10-10 | 武田薬品工業株式会社 | 固形製剤 |
GB0514203D0 (en) | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
EP1911738A4 (en) | 2005-07-29 | 2009-12-16 | Takeda Pharmaceutical | PHENOXYALKANSÄUREVERBINDUNG |
EP1916234B1 (en) | 2005-07-29 | 2014-11-12 | Takeda Pharmaceutical Company Limited | Cyclopropanecarboxylic acid compound |
AU2006277231A1 (en) | 2005-08-10 | 2007-02-15 | Takeda Pharmaceutical Company Limited | Therapeutic agent for diabetes |
JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
TWI354668B (en) | 2006-06-27 | 2011-12-21 | Takeda Pharmaceutical | Fused cyclic compounds |
WO2008047821A1 (fr) | 2006-10-18 | 2008-04-24 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique fusionné |
US7652133B2 (en) | 2006-10-19 | 2010-01-26 | Takeda Pharmaceutical Company Limited | Indole compound |
EP2128138A1 (en) | 2007-01-29 | 2009-12-02 | Takeda Pharmaceutical Company Limited | Pyrazole compound |
EP2118066A1 (en) | 2007-02-09 | 2009-11-18 | Takeda Pharmaceutical Company Limited | Fused ring compounds as partial agonists of ppar-gamma |
WO2008136428A1 (ja) | 2007-04-27 | 2008-11-13 | Takeda Pharmaceutical Company Limited | 含窒素5員複素環化合物 |
WO2008156757A1 (en) | 2007-06-19 | 2008-12-24 | Takeda Pharmaceutical Company Limited | Indazole compounds for activating glucokinase |
JP2010229034A (ja) | 2007-07-26 | 2010-10-14 | Dainippon Sumitomo Pharma Co Ltd | 二環性ピロール誘導体 |
US8466282B2 (en) | 2008-06-19 | 2013-06-18 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
JP4901849B2 (ja) | 2008-12-15 | 2012-03-21 | バブコック日立株式会社 | 空気清浄機、及び分析室、並びに空気の浄化方法 |
US8642622B2 (en) | 2010-06-16 | 2014-02-04 | Bristol-Myers Squibb Company | Piperidinyl compound as a modulator of chemokine receptor activity |
-
2011
- 2011-06-15 KR KR1020137000759A patent/KR20130119903A/ko active Search and Examination
- 2011-06-15 AU AU2011266099A patent/AU2011266099B2/en not_active Ceased
- 2011-06-15 SG SG2012090122A patent/SG186223A1/en unknown
- 2011-06-15 EA EA201291453A patent/EA022094B1/ru not_active IP Right Cessation
- 2011-06-15 EP EP11795784.5A patent/EP2583967B1/en active Active
- 2011-06-15 MY MYPI2012005311A patent/MY163927A/en unknown
- 2011-06-15 US US13/704,039 patent/US9018374B2/en not_active Expired - Fee Related
- 2011-06-15 JP JP2012520480A patent/JP5782438B2/ja not_active Expired - Fee Related
- 2011-06-15 ES ES11795784.5T patent/ES2524896T3/es active Active
- 2011-06-15 CA CA2802483A patent/CA2802483C/en not_active Expired - Fee Related
- 2011-06-15 UA UAA201300523A patent/UA108888C2/ru unknown
- 2011-06-15 GE GEAP201112963A patent/GEP20146195B/en unknown
- 2011-06-15 CN CN201180039608.XA patent/CN103068816B/zh active Active
- 2011-06-15 BR BR112012032055A patent/BR112012032055B8/pt not_active IP Right Cessation
- 2011-06-15 WO PCT/JP2011/063735 patent/WO2011158880A1/ja active Application Filing
- 2011-06-15 TW TW100120982A patent/TWI511967B/zh not_active IP Right Cessation
- 2011-06-15 MX MX2012014828A patent/MX2012014828A/es active IP Right Grant
- 2011-06-15 PE PE2012002427A patent/PE20130283A1/es active IP Right Grant
- 2011-06-16 MA MA35560A patent/MA34378B1/fr unknown
-
2012
- 2012-12-11 IL IL223562A patent/IL223562A/en active IP Right Grant
- 2012-12-13 CL CL2012003526A patent/CL2012003526A1/es unknown
- 2012-12-13 TN TNP2012000589A patent/TN2012000589A1/en unknown
- 2012-12-14 DO DO2012000313A patent/DOP2012000313A/es unknown
-
2013
- 2013-01-03 ZA ZA2013/00065A patent/ZA201300065B/en unknown
- 2013-01-15 CO CO13006575A patent/CO6670573A2/es unknown
- 2013-01-16 EC ECSP13012392 patent/ECSP13012392A/es unknown
- 2013-06-04 HK HK13106577.3A patent/HK1179605A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20130283A1 (es) | Cristal de compuesto de amida | |
PH12019500770A1 (en) | Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor | |
EA201590118A1 (ru) | Производные пирролидина и их применение в качестве модуляторов пути активации комплемента | |
EA201590200A1 (ru) | Модуляторы пути активации комплемента и их применение | |
CY1117085T1 (el) | C7-φθορο υποκατεστημενες ενωσεις τετρακυκλινης | |
CL2009000394A1 (es) | Compuestos derivados de n-(1h-indazol-5-il)pirrolidin-3-carboxamida sustituida, inhibidores de erk; composicion farmaceutica; y su uso en el tratamiento del cancer. | |
EA201290655A1 (ru) | Новые производные замещенного бициклического триазола в качестве модуляторов гамма-секретазы | |
PE20140011A1 (es) | Compuestos y composiciones novedosos para la inhibicion de nampt | |
PE20091556A1 (es) | Derivado heterociclico fusionado y su uso | |
CL2012001328A1 (es) | Compuestos derivados de (4,5,6,7-tetrahidro-1h-indazol-3-il)-1h-indol, inhibidores de itk; composicion farmaceutica; utiles en el tratamiento de enfermedades inflamatorias, tales como artritis reumatoidea, alergias, enfermedades autoinmunes, entre otras. | |
EA201290121A1 (ru) | Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов | |
EA201000113A1 (ru) | Пиразольные соединения | |
EA201490407A1 (ru) | Содержащие гидразид модуляторы нуклеарного транспорта и их применения | |
NZ621221A (en) | Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof | |
EA201071040A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40 | |
CL2013000308A1 (es) | Uso de compuestos heterociclicos con nitrogeno, oxigeno o azufre, para tratar una imperfeccion de la piel tal como una herida superficial, cicatriz o arruga; composiciones farmaceuticas. | |
NI200800169A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor | |
UA107967C2 (en) | Pharmaceutical composition in the form of bilayer tablets which contain inhibitor of hmg-coa reductase inhibitor and irbesartan | |
EA201100161A1 (ru) | Производные хинуклидина карбоната и их медицинские композиции | |
FR2968950B1 (fr) | Composition cosmetique comprenant un compose d'acide cucurbique | |
PE20140123A1 (es) | Formas cristalinas de la sal clorhidrato de (4a-r,9a-s)-1-(1h-benzoimidazol-5-carbonil)-2,3,4,4a,9,9a-hexahidro-1h-inden[2,1-b]piridin-6-carbonitrilo y su uso como inhibidores de hsd 1 | |
EA201071043A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 и cx3cr1 | |
TR201902057T4 (tr) | Tetrasiklin bileşikleri. | |
CO6460737A2 (es) | N-((1r,2s,5r)-5-(tert -butilamino)-2-((s)-3-(7-tert-butilpirazolo[1.5-a][1.3.5]traizin -4-ilamino)-2-oxopirrolidin-1-il)ciclohexil)acetamida, un modulador dual de la actividad del receptor de quimiocinas, formas cristalinas y procesos | |
BR112012015084A2 (pt) | composição farmacêutica de liberação lenta de iloperidone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |